MD Anderson researchers report early success of novel menin-targeted therapies in leukemia

  • Post author:
  • Post category:uncategorized

Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations.